IM Cannabis (IMCC) Other Non-Current Assets (2019 - 2026)
IM Cannabis' (IMCC) quarterly Other Non-Current Assets came in at $107922.4 in Q1 2026, up 141.96% year-on-year from $44602.7 in Q1 2025, and down 74.14% quarter-over-quarter from $417344.2 in Q4 2025.
IM Cannabis (IMCC) Other Non-Current Assets (2019 - 2026) Analysis & Trends
IM Cannabis' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $107922.4 for Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 141.96% year-over-year to $107922.4 in Q1 2026; TTM through Mar 2026 was $107922.4, a 141.96% increase from a year earlier, with the FY2025 full-year figure at $417344.2, up 792.8% from the prior year.
- Other Non-Current Assets slipped to $107922.4 in Q1 2026 per IMCC's latest filing, from $417344.2 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $46.5 million in Q3 2022 and bottomed at $28868.5 in Q2 2025.
- The 4-year median for Other Non-Current Assets is $107922.4 (2026), against an average of $7.2 million.
- Across the five-year window, Other Non-Current Assets jumped 810.95% in 2025 and surged 141.96% in 2026, its largest moves.
- Year by year, Other Non-Current Assets stood at $46.5 million in 2022, then slumped by 99.9% to $45814.3 in 2024, then soared by 810.95% to $417344.2 in 2025, then slumped by 74.14% to $107922.4 in 2026.
- Per Business Quant, the three latest IMCC Other Non-Current Assets figures stand at $107922.4 (Q1 2026), $417344.2 (Q4 2025), and $28868.5 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | 107,922.44 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107,922.44 |
| Dec 31, 2025 | 417,344.22 |
| Jun 30, 2025 | 28,868.50 |
| Mar 31, 2025 | 44,602.65 |
| Dec 31, 2024 | 45,814.34 |
| Sep 30, 2022 | 46.48 Mn |
| Mar 31, 2022 | 3.27 Mn |
| Dec 31, 2021 | 2.48 Mn |
| Dec 31, 2020 | 473,681.57 |
| Dec 31, 2019 | 59,824.95 |